ANN ARBOR, MI / May 16, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, is pleased to announce the interview with Juan Costello, Senior...
Zomedica Announces First Quarter 2022 Revenues of $3.8 Million; 74% Gross Margin & $192.3 Million in Cash; Revenue up 38% from 2021 Combined Revenues
ANN ARBOR, MI / May 10, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported consolidated financial results for the three months...
Zomedica® Supports Feline Animal Health With American Association of Feline Practitioners’ Sponsorship
ANN ARBOR, MI / May 4, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced its sponsorship with the American Association of Feline...
Zomedica to Present at H.C. Wainwright Global Investment Conference
ANN ARBOR, MI / April 27, 2022 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced today that Larry Heaton, Chief Executive Officer, will provide a strategic...
Zomedica’s Announces Designation of Pulsevet System as the Official Shock Wave Therapy of the American Quarter Horse Association
ANN ARBOR, MI / April 13, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, is pleased to announce that the PulseVet system has been named the...
Zomedica Announces Launch of eACTH Assay for Truforma® Platform
ANN ARBOR, MI / April 4, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced the commercial launch of its newest assay - endogenous...
Zomedica Corporation Reports 2021 Fourth Quarter & Full Year Results
ANN ARBOR, MI / March 1, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today reported consolidated financial results for the year ended December...
Zomedica Announces Fourth Quarter and 2021 Revenues of $4.1 Million; 73.9% Gross Margin
ANN ARBOR, MI / February 25, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced revenues and gross margin for the Fourth Quarter and...
Zomedica Appoints Adrian Lock to Lead Sales Organization
ANN ARBOR, MI / February 15, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that Adrian Lock, Vice President and General Manager,...
Zomedica Announces Management Team Additions
ANN ARBOR, MI / February 9, 2022 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced new additions to its management team.Management Team...